Lupin Limited has informed the Exchange regarding a press release dated January 05, 2023, titled "Lupin Launches novel fixed-dose triple drug combination DIFIZMA�� DPI to TreatInadequately Controlled Asthma.".
Lupin Limited has informed the Exchange regarding a press release dated January 05, 2023, titled "Lupin Launches novel fixed-dose triple drug combination DIFIZMA�� DPI to TreatInadequately Controlled Asthma.".